Coronary Artery Bypass Grafting Following ST Elevation Myocardial Infarction Outcomes Are Associated with Time to

Joshua G Crane1, Jaimin Trivedi1, Toyokazu Endo1

  • 1Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY 40202, United States.

Insights

Timing coronary artery bypass grafting (CABG) after ST-elevation myocardial infarction (STEMI) impacts outcomes. Performing CABG 2-15 days post-STEMI is associated with the lowest in-hospital mortality risk.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Health Services Research

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition requiring timely intervention.
  • Coronary artery bypass grafting (CABG) is performed in 5-10% of STEMI patients during the same hospital admission.
  • The optimal timing for CABG after STEMI is not well-defined, influencing patient outcomes.

Purpose of the Study:

  • To analyze the impact of time from STEMI to CABG on operative mortality, morbidity, length of hospital stay, and cost.
  • To identify the optimal timing window for performing CABG after STEMI to minimize adverse events.

Main Methods:

  • Utilized the Healthcare Cost and Utilization Project (HCUP) database from 2016-2022.
  • Analyzed 11,974 STEMI patients who underwent CABG during the same hospitalization.
  • Grouped patients by time from STEMI to CABG: <48 hours, 2-7 days, 8-15 days, and ≥16 days.
  • Compared demographics, characteristics, mortality, length of stay, and cost using univariable and multivariable logistic regression.

Main Results:

  • In-hospital mortality was highest for CABG performed <48 hours (6%) and ≥16 days (5%) post-STEMI.
  • Length of stay and costs were significantly greater for patients undergoing CABG ≥16 days after STEMI.
  • Performing CABG 2-7 days after STEMI was associated with decreased in-hospital mortality (OR 0.585).

Conclusions:

  • The optimal window for post-STEMI CABG is between 2 and 15 days, offering the lowest in-hospital mortality risk.
  • Early (<48 hours) or delayed (≥16 days) CABG after STEMI is associated with increased mortality.
  • This study provides evidence for optimizing surgical timing to improve outcomes for STEMI patients requiring CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.5K